| Miss Rochelle George, | |
|
1910 Pacific Ave Ste 9550, Dallas, TX 75201-4913 | |
| (214) 643-6820 | |
| Not Available |
| Full Name | Miss Rochelle George |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Psychiatric/mental Health |
| Location | 1910 Pacific Ave Ste 9550, Dallas, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275875122 | NPI | - | NPPES |
| Entity Name | Texas Advance Behavioral Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730567462 PECOS PAC ID: 5991014391 Enrollment ID: O20151027000331 |
News Archive
Cardiome Pharma Corp. today announced that the company has entered a commercialization agreement with AOP Orphan Pharma to sell AOP's cardiovascular products, ESMOCARD and ESMOCARD LYO (esmolol hydrochloride) in Italy, France, Spain and Belgium.
Van Andel Research Institute researchers have developed a method that can yield more information from archived newborn blood that has implications for a vast array of research, including population health studies and answering questions about diseases in infants and children.
A recent, updated predictive analysis of the three WHO-defined molecular subgroups based on isocitrate dehydrogenase 1/2 (IDH) mutation status and 1p/19q co-deletion status represented in the high-risk treatment arms of the NRG Oncology clinical trial NRG-RTOG 9802 indicates that both IDH-mutant sub-groups (IDHmut-noncodel and IDHmut-codel) could benefit from the addition of PCV chemotherapy to radiotherapy treatment.
There's more evidence of tart cherries' powerful anti-inflammatory benefits, according to a new study presented by a team of Michigan researchers today at the Experimental Biology annual meeting.
› Verified 6 days ago
| Entity Name | Ziks Health Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427521426 PECOS PAC ID: 4981033289 Enrollment ID: O20200408001955 |
News Archive
Cardiome Pharma Corp. today announced that the company has entered a commercialization agreement with AOP Orphan Pharma to sell AOP's cardiovascular products, ESMOCARD and ESMOCARD LYO (esmolol hydrochloride) in Italy, France, Spain and Belgium.
Van Andel Research Institute researchers have developed a method that can yield more information from archived newborn blood that has implications for a vast array of research, including population health studies and answering questions about diseases in infants and children.
A recent, updated predictive analysis of the three WHO-defined molecular subgroups based on isocitrate dehydrogenase 1/2 (IDH) mutation status and 1p/19q co-deletion status represented in the high-risk treatment arms of the NRG Oncology clinical trial NRG-RTOG 9802 indicates that both IDH-mutant sub-groups (IDHmut-noncodel and IDHmut-codel) could benefit from the addition of PCV chemotherapy to radiotherapy treatment.
There's more evidence of tart cherries' powerful anti-inflammatory benefits, according to a new study presented by a team of Michigan researchers today at the Experimental Biology annual meeting.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Miss Rochelle George, 141 E Main St, Waterbury, CT 06702-2310 Ph: (203) 574-9000 | Miss Rochelle George, 1910 Pacific Ave Ste 9550, Dallas, TX 75201-4913 Ph: (214) 643-6820 |
News Archive
Cardiome Pharma Corp. today announced that the company has entered a commercialization agreement with AOP Orphan Pharma to sell AOP's cardiovascular products, ESMOCARD and ESMOCARD LYO (esmolol hydrochloride) in Italy, France, Spain and Belgium.
Van Andel Research Institute researchers have developed a method that can yield more information from archived newborn blood that has implications for a vast array of research, including population health studies and answering questions about diseases in infants and children.
A recent, updated predictive analysis of the three WHO-defined molecular subgroups based on isocitrate dehydrogenase 1/2 (IDH) mutation status and 1p/19q co-deletion status represented in the high-risk treatment arms of the NRG Oncology clinical trial NRG-RTOG 9802 indicates that both IDH-mutant sub-groups (IDHmut-noncodel and IDHmut-codel) could benefit from the addition of PCV chemotherapy to radiotherapy treatment.
There's more evidence of tart cherries' powerful anti-inflammatory benefits, according to a new study presented by a team of Michigan researchers today at the Experimental Biology annual meeting.
› Verified 6 days ago
Mrs. Darleen Dansby, APN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1513 Viceroy Dr, Dallas, TX 75235 Phone: 469-685-7020 Fax: 214-920-7020 | |
Ms. Kimberley Shenee Player, MSN, APRN, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 8604 Greenville Ave Ste 103a, Dallas, TX 75243 Phone: 214-702-5855 | |
Teresa Anna Jones, CPNP-AC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1935 Medical District Dr, Dallas, TX 75235 Phone: 973-801-0173 | |
Christina Hagood, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 6301 Gaston Ave, Suite 100, West Tower, Dallas, TX 75214 Phone: 214-827-3610 Fax: 214-821-4017 | |
Susan C. Chesire, ANP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3600 Gaston Ave, Wadley Tower, Suite 651, Dallas, TX 75246 Phone: 214-820-9115 Fax: 214-820-9135 | |
Mrs. Larah Brown, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3209 W Camp Wisdom Rd, Dallas, TX 75237 Phone: 469-966-9660 Fax: 877-667-6112 | |
Michele Willet Rylander, RN, MSN, CPNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1935 Medical District Dr, Dallas, TX 75235 Phone: 214-456-7000 |